Evoq Remedies Ltd — Others, 09-05-2025: AGM/EGM

Evoq Remedies Limited has announced a board meeting to call an Extra-Ordinary General Meeting (EGM) to approve an increase in Authorized Share Capital from Rs. 25 Cr to Rs. 42 Cr. The company proposes two preferential share issues for share swaps to acquire majority stakes in Spazio Formulations Limited and Poshan Nutriwell Private Limited. Up to 1 Cr equity shares will be issued to non-promoter shareholders of Spazio Formulations for acquiring 50.36% stake, and up to 63.36 lakh shares to the promoter of Poshan Nutriwell for acquiring 71.95% stake, both at Rs. 10 per share based on valuation by a Registered Valuer. No change in management control is expected. The company also plans to expand its business scope by altering its object clause to include trading and processing of diverse agricultural and agro-based products. The equity shares will rank equally with existing shares and will be subject to lock-in as per regulations. Remote e-voting and participation facilities are arranged for shareholders.